Breast Conservation Treatment for Patients Presenting with Axillary Lymphadenopathy from Presumed Primary Breast Cancer: The Role of Breast Magnetic Resonance Imaging for Staging

2002 ◽  
Vol 3 (3) ◽  
pp. 219-222 ◽  
Author(s):  
Changhu Chen ◽  
Susan G. Orel ◽  
Mitchell D. Schnall ◽  
Eleanor Harris ◽  
Lawrence J. Solin
Keyword(s):  
Breast Cancer ◽  
Magnetic Resonance Imaging ◽  
Breast Magnetic Resonance Imaging ◽  
Breast Conservation ◽  
Resonance Imaging ◽  
Axillary Lymphadenopathy ◽  
Conservation Treatment ◽  
Breast Conservation Treatment ◽  
Breast Magnetic Resonance

scholarly journals Breast cancer and background parenchymal enhancement at breast magnetic resonance imaging: a meta-analysis

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Na Hu ◽  
Jinghao Zhao ◽  
Yong Li ◽  
Quanshui Fu ◽  
Linwei Zhao ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Breast Magnetic Resonance Imaging ◽  
Meta Analysis ◽  
Resonance Imaging ◽  
High Background ◽  
Background Parenchymal Enhancement ◽  
Breast Magnetic Resonance ◽  
Parenchymal Enhancement

Abstract Background The background parenchymal enhancement at breast magnetic resonance imaging use to predict breast cancer attracts many searchers to draw a possible relationship. However, the results of their relationships were conflicting. This meta-analysis was performed to assess breast cancer frequency associations with background parenchymal enhancement. Methods A systematic literature search up to January 2020 was performed to detect studies recording associations between breast cancer frequency and background parenchymal enhancement. We found thirteen studies including 13,788 women at the start with 4046 breast cancer. We calculated the odds ratio (OR) and the 95% confidence intervals (CIs) between breast cancer frequency and background parenchymal enhancement by the dichotomous technique with a random or fixed-effect model. Results Women with minimal or mild background parenchymal enhancement at breast magnetic resonance imaging did not have any risk of breast cancer compared to control women (OR, 1.20; 95% CI 0.54–2.67). However, high background parenchymal enhancement at breast magnetic resonance imaging (OR, 2.66; 95% CI 1.36–5.19) and moderate (OR, 2.51; 95% CI 1.49–4.21) was associated with a significantly higher rate of breast cancer frequency compared to control women. Conclusions Our meta-analysis showed that the women with high and moderate background parenchymal enhancement at breast magnetic resonance imaging have higher risks, up to 2.66 fold, of breast cancer. We suggest that women with high or moderate background parenchymal enhancement at breast magnetic resonance imaging to be scheduled for more frequent follow-up and screening for breast cancer to avoid any complications.

Radioguided Surgery Using Intravenous 99mTc Sestamibi Associated with Breast Magnetic Resonance Imaging for Guidance of Breast Cancer Resection

2006 ◽  
Vol 12 (3) ◽  
pp. 202-207 ◽  
Author(s):  
Giuliano Mendes Duarte ◽  
Cesar Cabello dos Santos ◽  
Renato Zocchio Torresan ◽  
Marcelo Alvarenga ◽  
Gilliat H. Q. Telles ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Breast Magnetic Resonance Imaging ◽  
Radioguided Surgery ◽  
Resonance Imaging ◽  
Cancer Resection ◽  
Breast Magnetic Resonance ◽  
99Mtc Sestamibi
Sign in / Sign up

Export Citation Format

Share Document